Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation.
paper
Cited
Public
Unavailable
- Authors
- Sumislawski, Joshua J; Ramikie, Teniel S; Patel, Sachin
- Year
- 2011
- Journal
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- PMID
- 21849983
- DOI
- 10.1038/npp.2011.166
- PMCID
- PMC3230498
Chronic stress is the primary environmental risk factor for the development and exacerbation of affective disorders, thus understanding the neuroadaptations that occur in response to stress is a critical step in the development of novel therapeutics for depressive and anxiety disorders. Brain endocannabinoid (eCB) signaling is known to modulate emotional behavior and stress responses, and levels of the eCB 2-arachidonoylglycerol (2-AG) are elevated in response to chronic homotypic stress exposure. However, the role of 2-AG in the synaptic and behavioral adaptations to chronic stress is poorly understood. Here, we show that stress-induced development of anxiety-like behavior is paralleled by a transient appearance of low-frequency stimulation-induced, 2-AG-mediated long-term depression at GABAergic synapses in the basolateral amygdala, a key region involved in motivation, affective regulation, and emotional learning. This enhancement of 2-AG signaling is mediated, in part, via downregulation of the primary 2-AG-degrading enzyme monoacylglycerol lipase (MAGL). Acute in vivo inhibition of MAGL had little effect on anxiety-related behaviors. However, chronic stress-induced anxiety-like behavior and emergence of long-term depression of GABAergic transmission was prevented by chronic MAGL inhibition, likely via an occlusive mechanism. These data indicate that chronic stress reversibly gates eCB synaptic plasticity at inhibitory synapses in the amygdala, and in vivo augmentation of 2-AG levels prevents both behavioral and synaptic adaptations to chronic stress.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy. | Pakkhesal S et al. | β | 2025 | β |
| Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. | Loomba N et al. | β | 2025 | β |
| Mechanisms and pharmacotherapy of cancer cachexia-associated anorexia. | Sato R et al. | β | 2025 | β |
| Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia. | MartΓnez-Rivera A et al. | β | 2024 | β |
| Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs. | Zhao H et al. | β | 2024 | β |
| Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress. | Gowatch LC et al. | β | 2024 | β |
| Sex Differences in Mouse Models of Voluntary Alcohol Drinking and Abstinence-Induced Negative Emotion. | Salazar AL et al. | β | 2024 | β |
| The Estrous Cycle Influences the Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition in the Anxiety-Like Behavior in Rats. | Salemme BW et al. | β | 2024 | β |
| Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment. | Scheyer A et al. | β | 2023 | β |
| Metabolic and Transcriptomic Signatures of the Acute Psychological Stress Response in the Mouse Brain. | Lee H et al. | β | 2023 | β |
| Potential Utility of Cannabidiol in Stress-Related Disorders. | Lookfong NA et al. | β | 2023 | β |
| Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress-related behaviour and drinking in Marchigian Sardinian alcohol-preferring rats. | Vozella V et al. | β | 2023 | β |
| The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. | Hill MN et al. | β | 2023 | β |
| Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms. | SΓ‘nchez-MarΓn L et al. | β | 2022 | β |
| Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes. | Serrano A et al. | β | 2022 | β |
| Chronic Pain and the Endocannabinoid System: Smart Lipids - A Novel Therapeutic Option? | ZieglgΓ€nsberger W et al. | β | 2022 | β |
| Effects of Environmental Heat Load on Endocannabinoid System Components in Adipose Tissue of High Yielding Dairy Cows. | Kra G et al. | β | 2022 | β |
| Endocannabinoid system reactivity during stress processing in healthy humans. | Spohrs J et al. | β | 2022 | β |
| Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. | Haney M et al. | β | 2022 | β |
| Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. | Morris G et al. | β | 2022 | β |
| The cannabinoid receptor-1 gene interacts with stressful life events to increase the risk for problematic alcohol use. | Bornscheuer L et al. | β | 2022 | β |
| The Endocannabinoid 2-Arachidonoylglycerol Bidirectionally Modulates Acute and Protracted Effects of Predator Odor Exposure. | Kondev V et al. | β | 2022 | β |
| Cannabinoid receptor 1 signalling modulates stress susceptibility and microglial responses to chronic social defeat stress. | Beins EC et al. | β | 2021 | β |
| Chronic Augmentation of Endocannabinoid Levels Persistently Increases Dopaminergic Encoding of Reward Cost and Motivation. | Covey DP et al. | β | 2021 | β |
| Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase. | Vecchiarelli HA et al. | β | 2021 | β |
| Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression. | Gallego-Landin I et al. | β | 2021 | β |
| The endocannabinoid system in the amygdala and modulation of fear. | Gunduz-Cinar O | β | 2021 | β |
| Traumatic Stress, Chronic Ethanol Exposure, or the Combination, Alter Cannabinoid System Components in Reward and Limbic Regions of the Mouse Brain. | Piggott VM et al. | β | 2021 | β |
| 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics. | Bedse G et al. | β | 2020 | β |
| Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB<sub>2</sub> receptors. | Corcoran L et al. | β | 2020 | β |
| Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala. | SuΓ‘rez J et al. | β | 2020 | β |
| Druggable Targets in Endocannabinoid Signaling. | Gregus AM et al. | β | 2020 | β |
| Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening. | Marcus DJ et al. | β | 2020 | β |
| Meet Your Stress Management Professionals: The Endocannabinoids. | deRoon-Cassini TA et al. | β | 2020 | β |
| Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. | Grimsey NL et al. | β | 2020 | β |
| Temporal Gating of Synaptic Competition in the Amygdala by Cannabinoid Receptor Activation. | Madeira N et al. | β | 2020 | β |
| Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. | Centanni SW et al. | β | 2019 | β |
| Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference. | Kirchhoff AM et al. | β | 2019 | β |
| 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. | Baggelaar MP et al. | β | 2018 | β |
| Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake. | Serrano A et al. | β | 2018 | β |
| Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors. | Aida J et al. | β | 2018 | β |
| Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. | Boero G et al. | β | 2018 | β |
| Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice. | Cavener VS et al. | β | 2018 | β |
| Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. | Hill MN et al. | β | 2018 | β |
| Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia. | Clarke DJ et al. | β | 2017 | β |
| Endocannabinoids: Effectors of glucocorticoid signaling. | Balsevich G et al. | β | 2017 | β |
| Endocannabinoid signaling and memory dynamics: A synaptic perspective. | Drumond A et al. | β | 2017 | β |
| Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. | Bluett RJ et al. | β | 2017 | β |
| Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. | Bedse G et al. | β | 2017 | β |
| Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling. | Grabner GF et al. | β | 2017 | β |
| The endocannabinoid system as a target for novel anxiolytic drugs. | Patel S et al. | β | 2017 | β |
| 2-arachidonoylglycerol signaling impairs short-term fear extinction. | Hartley ND et al. | β | 2016 | β |
| Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. | Gamble-George JC et al. | β | 2016 | β |
| Dendritic Spines in Depression: What We Learned from Animal Models. | Qiao H et al. | β | 2016 | β |
| Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis. | Hillard CJ et al. | β | 2016 | β |
| Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking. | Holleran KM et al. | β | 2016 | β |
| Neurobiological Interactions Between Stress and the Endocannabinoid System. | Morena M et al. | β | 2016 | β |
| Orbitofrontal cortex 5-HT2A receptor mediates chronic stress-induced depressive-like behaviors and alterations of spine density and Kalirin7. | Xu C et al. | β | 2016 | β |
| The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors. | Zhou WJ et al. | β | 2016 | β |
| Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. | Zhang Z et al. | β | 2015 | β |
| Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling. | Qin Z et al. | β | 2015 | β |
| Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase. | Del Carlo S et al. | β | 2015 | β |
| Embedded synaptic feedback in the neuroendocrine stress axis. | Wamsteeker Cusulin JI et al. | β | 2015 | β |
| Endocannabinoid Regulation of Neuroendocrine Systems. | Tasker JG et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. | Lee SH et al. | β | 2015 | β |
| The Endocannabinoid Signaling System in the CNS: A Primer. | Hillard CJ | β | 2015 | β |
| The endocannabinoid system in guarding against fear, anxiety and stress. | Lutz B et al. | β | 2015 | β |
| The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs--A practical view. | Fowler CJ | β | 2015 | β |
| Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. | Lomazzo E et al. | β | 2015 | β |
| Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats. | Morena M et al. | β | 2015 | β |
| A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. | McLaughlin RJ et al. | β | 2014 | β |
| Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. | Kohnz RA et al. | β | 2014 | β |
| Endocannabinoid signaling in the etiology and treatment of major depressive illness. | Hillard CJ et al. | β | 2014 | β |
| Endogenous cannabinoid signaling at inhibitory interneurons. | Younts TJ et al. | β | 2014 | β |
| Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. | Shonesy BC et al. | β | 2014 | β |
| Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. | Melis M et al. | β | 2014 | β |
| Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. | Zhong P et al. | β | 2014 | β |
| Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. | Ramikie TS et al. | β | 2014 | β |
| Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. | Murataeva N et al. | β | 2014 | β |
| Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. | Nader J et al. | β | 2014 | β |
| Stress regulates endocannabinoid-CB1 receptor signaling. | Hillard CJ | β | 2014 | β |
| The endocannabinoid/endovanilloid system and depression. | Smaga I et al. | β | 2014 | β |
| Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. | Reich CG et al. | β | 2013 | β |
| Amygdala FAAH and anandamide: mediating protection and recovery from stress. | Gunduz-Cinar O et al. | β | 2013 | β |
| CaMKII regulates diacylglycerol lipase-Ξ± and striatal endocannabinoid signaling. | Shonesy BC et al. | β | 2013 | β |
| Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats. | Reich CG et al. | β | 2013 | β |
| Changing the tune: plasticity and adaptation of retrograde signals. | Iremonger KJ et al. | β | 2013 | β |
| Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. | Hill MN et al. | β | 2013 | β |
| Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. | Gamble-George JC et al. | β | 2013 | β |
| Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses. | Wamsteeker Cusulin JI et al. | β | 2013 | β |
| Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. | Hermanson DJ et al. | β | 2013 | β |
| Therapeutic potential of monoacylglycerol lipase inhibitors. | Mulvihill MM et al. | β | 2013 | β |
| Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. | Hill MN et al. | β | 2013 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. | Roberts CJ et al. | β | 2012 | β |